Literature DB >> 15296939

Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon.

Annemarie J van der Slot1, Anne-Marie Zuurmond, Antoon J van den Bogaerdt, Magda M W Ulrich, Esther Middelkoop, Willem Boers, H Karel Ronday, Jeroen DeGroot, Tom W J Huizinga, Ruud A Bank.   

Abstract

Fibrosis is characterized by an excessive accumulation of collagen which contains increased levels of pyridinoline cross-links. The occurrence of pyridinolines in the matrix is an important criterion in assessing the irreversibility of fibrosis, which suggests that collagen containing pyridinoline cross-links significantly contributes to the unwanted collagen accumulation. Pyridinoline cross-links are derived from hydroxylated lysine residues located within the collagen telopeptides (hydroxyallysine pathway). Here, we have investigated whether the increase in hydroxyallysine-derived cross-links in fibrotic conditions can be ascribed to an increased expression of one of the lysyl hydroxylases (LH1, LH2 with its splice variants LH2a and LH2b, or LH3) and/or to an increased expression of lysyl oxidase (LOX). In fibroblast cultures of hypertrophic scars, keloid and palmar fascia of Dupuytren's patients, as well as in activated hepatic stellate cells, increased levels of LH2b mRNA expression were observed. Only minor amounts of LH2a were present. In addition, no consistent increase in the mRNA expression levels of LH1, LH3 and LOX could be detected, suggesting that LH2b is responsible for the overhydroxylation of the collagen telopeptides and the concomitant formation of pyridinolines as found in the collagen matrix deposited in long-term cultures by the same fibrotic cells. This is consistent with our previous observation that LH2b is a telopeptide lysyl hydroxylase. We conclude that the increased expression of LH2b, leading to the increased formation of pyridinoline cross-links, is present in a wide variety of fibrotic disorders and thus represents a general fibrotic phenomenon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296939     DOI: 10.1016/j.matbio.2004.06.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  65 in total

Review 1.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 2.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

Review 3.  The myofibroblast, a key cell in normal and pathological tissue repair.

Authors:  Ian A Darby; Noraina Zakuan; Fabrice Billet; Alexis Desmoulière
Journal:  Cell Mol Life Sci       Date:  2015-12-17       Impact factor: 9.261

4.  Ochratoxin A-induced renal cortex fibrosis and epithelial-to-mesenchymal transition: molecular mechanisms of ochratoxin A-injury and potential effects of red wine.

Authors:  Nicoletta Gagliano; Carlo Torri; Elena Donetti; Fabio Grizzi; Francesco Costa; Alberto A E Bertelli; Massimiliano Migliori; Cristina Filippi; Marzia Bedoni; Vincenzo Panichi; Luca Giovannini; Magda Gioia
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 5.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

6.  Interleukin-4 Receptor α Signaling in Myeloid Cells Controls Collagen Fibril Assembly in Skin Repair.

Authors:  Johanna A Knipper; Sebastian Willenborg; Jürgen Brinckmann; Wilhelm Bloch; Tobias Maaß; Raimund Wagener; Thomas Krieg; Tara Sutherland; Ariel Munitz; Marc E Rothenberg; Anja Niehoff; Rebecca Richardson; Matthias Hammerschmidt; Judith E Allen; Sabine A Eming
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

7.  Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.

Authors:  Thilo J Witsch; Pawel Turowski; Elpidoforos Sakkas; Gero Niess; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

8.  Effects of aging and cyclosporin a on collagen turnover in human gingiva.

Authors:  N Gagliano; F Costa; G M Tartaglia; L Pettinari; F Grizzi; C Sforza; N Portinaro; M Gioia; G Annoni
Journal:  Open Dent J       Date:  2009-11-05

9.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Reduction of lysyl hydroxylase 3 causes deleterious changes in the deposition and organization of extracellular matrix.

Authors:  Maija Risteli; Heli Ruotsalainen; Antti M Salo; Raija Sormunen; Laura Sipilä; Naomi L Baker; Shireen R Lamandé; Leena Vimpari-Kauppinen; Raili Myllylä
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.